Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The updated 2025 classification for interstitial pneumonia: Are we ready for the entity "idiopathic bronchiolocentric interstitial pneumonia?"

Lung India : official organ of Indian Chest Society·2026

Same author

Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026

Same author

Association between anti-citrullinated peptide antibodies and subclinical interstitial lung disease in community-dwelling adults: the multi-ethnic study of atherosclerosis.

Respiratory research·2026

Same author

Pulmonary Hypertension Associated With Interstitial Lung Disease: State-of-the-Art Review.

The European respiratory journal·2026

Same author

Rebuttal to "Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: pro".

American journal of respiratory and critical care medicine·2026

Same author

Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: con.

American journal of respiratory and critical care medicine·2026

Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026

Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026

Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026

Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026

Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026

Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Systemic sclerosis-associated interstitial lung disease.

Ciaran J Scallan¹, Bridget F Collins², Ganesh Raghu²

¹Firestone Institute for Respiratory Health, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Current Opinion in Pulmonary Medicine

|August 3, 2020

Summary

This summary is machine-generated.

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a leading cause of mortality. Early diagnosis and management with immunomodulation and antifibrotic agents are crucial for improving outcomes in SSc-ILD patients.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Related Experiment Videos

Last Updated: Dec 13, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Area of Science:

Pulmonary Medicine
Rheumatology
Immunology

Background:

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is increasingly recognized as a major cause of mortality in systemic sclerosis (SSc).
Advances in SSc management highlight the critical need for effective SSc-ILD diagnosis, surveillance, and treatment strategies.
Early detection and intervention are paramount for improving patient prognosis.

Purpose of the Study:

To review recent developments in the diagnosis, surveillance, and management of SSc-ILD.
To highlight the evolving therapeutic landscape for SSc-ILD.
To emphasize the importance of early detection and comprehensive patient management.

Main Methods:

Literature review focusing on recent studies and clinical trials.
Analysis of diagnostic tools including lung function testing and chest imaging.
Evaluation of current and emerging therapeutic strategies for SSc-ILD.

Main Results:

Lung function testing and chest imaging are essential for SSc-ILD diagnosis and surveillance.
Immunomodulation remains a cornerstone of treatment, with new agents under investigation.
Therapies targeting pro-fibrotic pathways show significant benefits in slowing lung function decline.

Conclusions:

Antifibrotic agents represent a significant advancement in SSc-ILD therapy.
Management of comorbidities and consideration of lung transplantation are important for advanced disease.
Integrated approaches to diagnosis, surveillance, and treatment are vital for optimizing SSc-ILD care.